{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:18:19Z","timestamp":1791415099976,"version":"4.3.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T00:00:00Z","timestamp":1444608000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s40258-015-0202-5","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T02:47:22Z","timestamp":1444704442000},"page":"135-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Tegaderm CHG IV Securement Dressing for Central Venous and Arterial Catheter Insertion Sites: A NICE Medical Technology Guidance"],"prefix":"10.1007","volume":"14","author":[{"given":"Michelle","family":"Jenks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mick","family":"Arber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,12]]},"reference":[{"key":"202_CR1","unstructured":"National Institute for Health and Care Excellence. The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites. 2015. https:\/\/www.nice.org.uk\/guidance\/MTG25 . Accessed 23 July 2015."},{"issue":"5","key":"202_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF03261863","volume":"10","author":"B Campbell","year":"2012","unstructured":"Campbell B, Campbell M. NICE medical technologies guidance: a novel and rigorous methodology to address a new health technology assessment challenge. Appl Health Econ Health Policy. 2012;10(5):295\u20137.","journal-title":"Appl Health Econ Health Policy."},{"key":"202_CR3","unstructured":"3M. Instructions For Use: 3M\u2122 Tegaderm\u2122 CHG Chlorhexidine Gluconate I.V. Securement Dressing [obtained via sponsor\u2019s submission]. 2012."},{"key":"202_CR4","unstructured":"Health and Social Care Information Centre. Hospital Episode Statistics: Adult Critical Care in England April 2012 to March 2013. 2014. http:\/\/www.hscic.gov.uk\/catalogue\/PUB13893\/adul-crit-care-data-eng-apr-12-mar-13-rep.pdf . Accessed 23 Dec 2014."},{"issue":"2","key":"202_CR5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/175114370901000208","volume":"10","author":"RL Curtis","year":"2009","unstructured":"Curtis RL. Catheter-related bloodstream infection in the intensive care unit. J Intensive Care Soc. 2009;10(2):102\u20138.","journal-title":"J Intensive Care Soc."},{"key":"202_CR6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bmjqs-2012-001325","volume":"22","author":"JF Bion","year":"2013","unstructured":"Bion JF, Richardson A, Hibbert P, et al. \u2018Matching Michigan\u2019: a 2-year stepped interventional programme to minimise central venous catheterblood stream infections in intensive care units in England. BMJ Qual Saf. 2013;22:110\u201323.","journal-title":"BMJ Qual Saf."},{"issue":"3","key":"202_CR7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/1941874413476043","volume":"3","author":"H Shah","year":"2013","unstructured":"Shah H, Bosch W, Thompson KM, Hellinger WC. Intravascular catheter-related bloodstream infection. Neurohospitalist. 2013;3(3):144\u201351.","journal-title":"Neurohospitalist."},{"issue":"2","key":"202_CR8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/bjaceaccp\/mki011","volume":"5","author":"S Fletcher","year":"2005","unstructured":"Fletcher S. Catheter-related bloodstream infection. Contin Educ Anaesth Crit Care Pain. 2005;5(2):49\u201351.","journal-title":"Contin Educ Anaesth Crit Care Pain."},{"key":"202_CR9","unstructured":"National Institute for Health and Care Excellence. Infection: prevention and control of healthcare-associated infections in primary and community care. 2012. https:\/\/www.nice.org.uk\/guidance\/cg139 . Accessed 12 Dec 2014."},{"key":"202_CR10","unstructured":"National Institute for Health and Care Excellence. The 3M Tegaderm CHG IV securement dressing for cnetral venous and arterial catheter insertion sites: final scope. 2014. https:\/\/www.nice.org.uk\/guidance\/gid-mt238\/documents\/the-3m-tegaderm-chg-iv-securement-dressing-for-central-venous-and-arterial-catheter-insertion-sites-final-scope2 . Accessed 9 Apr 2015."},{"issue":"12","key":"202_CR11","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1164\/rccm.201206-1038OC","volume":"186","author":"JF Timsit","year":"2012","unstructured":"Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S, et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med. 2012;186(12):1272\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"202_CR12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/jama.2009.376","volume":"301","author":"JF Timsit","year":"2009","unstructured":"Timsit JF, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA. 2009;301(12):1231\u201341.","journal-title":"JAMA"},{"key":"202_CR13","unstructured":"National Institute for Health and Care Excellence. Medical Technologies Evaluation Programme: Process Guide. 2011. http:\/\/www.nice.org.uk\/Media\/Default\/About\/what-we-do\/NICE-guidance\/NICE-medical-technologies\/Medical-technologies-evaluation-programme-process-guide.pdf . Accessed 6 Feb 2015."},{"issue":"4","key":"202_CR14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ajic.2011.03.030","volume":"40","author":"MH Bashir","year":"2012","unstructured":"Bashir MH, Olson LK, Walters SA. Suppression of regrowth of normal skin flora under chlorhexidine gluconate dressings applied to chlorhexidine gluconate-prepped skin. Am J Infect Control. 2012;40(4):344\u20138.","journal-title":"Am J Infect Control"},{"issue":"4","key":"202_CR15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2309\/java.14-4-5","volume":"14","author":"K Maryniak","year":"2009","unstructured":"Maryniak K. Clinical performance and nursing satisfaction of a transparent chlorhexidine gluconate IV securement dressing with peripherally inserted central catheters. J Assoc Vasc Access. 2009;14(4):200\u20133.","journal-title":"J Assoc Vasc Access."},{"issue":"1","key":"202_CR16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2309\/java.13-1-4","volume":"13","author":"C Olson","year":"2008","unstructured":"Olson C, Heilman JM. Clinical performance of a new transparent chlorhexidine gluconate central venous catheter dressing. J Assoc Vasc Access. 2008;13(1):13\u20139.","journal-title":"J Assoc Vasc Access."},{"key":"202_CR17","unstructured":"Rupp ME, Cavalieri J, Delaney K, Lundgren K, Stammers L, Beach S, editors. Prospective, randomized, controlled trial assessing the clinical performance of a transparent chlorhexidine gel pad intravascular catheter dressing. 18th Annual Meeting of the Society for Healthcare Epidemiology of America; 5th\u20138th April 2008; Orlando."},{"issue":"7716","key":"202_CR18","first-page":"332","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br Med J. 2009;339(7716):332 (D. A.).","journal-title":"Br Med J"},{"key":"202_CR19","unstructured":"Karpanen T, Casey A, Nightingale P, Whitehouse T, Das I, Elliott TSJ, editors. A clinical study on the antimicrobial efficacy of a transparent chlorhexidine gel pad intravascular catheter dressing. Hospital Infection Society Conference; 16\u201318th Nov 2014; Lyon."},{"issue":"1","key":"202_CR20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1036-7314(98)70426-6","volume":"11","author":"B Roberts","year":"1998","unstructured":"Roberts B, Cheung D. Biopatch\u2013a new concept in antimicrobial dressings for invasive devices. Aust Crit Care. 1998;11(1):16\u20139.","journal-title":"Aust Crit Care."},{"key":"202_CR21","unstructured":"Deschneau M, Pyrek J, Moureau NL, editors. A Multicenter prospective open label evaluation of the clinical performance of a chlorhexidine gluconate antimicrobial transparent dressing. Infusion Nurses Society Conference; 2008."},{"issue":"3","key":"202_CR22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2309\/java.13-3-3","volume":"13","author":"CI Eyberg","year":"2008","unstructured":"Eyberg CI, Pyrek J. A controlled randomized prospective comparative pilot study to evaluate the ease of use of a transparent chlorhexidine gluconate gel dressing versus a chlorhexidine gluconate disk in healthy volunteers. J Assoc Vasc Access. 2008;13(3):112\u20137.","journal-title":"J Assoc Vasc Access."},{"key":"202_CR23","unstructured":"Zehrer CL, Smith GD, Deschneau M, editors. Evaluation of a new CHG gel pad dressing for catheter care. Infusion Nursing Society; 16th\u201321st May 2009; Nashville."},{"issue":"8","key":"202_CR24","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1086\/502459","volume":"25","author":"AGF Crawford","year":"2004","unstructured":"Crawford AGF, Joseph P Jr, Rao B Jr. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections. Infect Control Hosp Epidemiol. 2004;25(8):668\u201374.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"202_CR25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3310\/hta12120","volume":"12","author":"JC Hockenhull","year":"2008","unstructured":"Hockenhull JC, Dwan K, Boland A, Smith G, Bagust A. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess. 2008;12(12):154.","journal-title":"Health Technol Assess"},{"key":"202_CR26","doi-asserted-by":"crossref","unstructured":"Schwebel C, Lucet JC, Vesin A, Arrault X, Calvino-Gunther S, Bouadma L, Timsit, JF. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study. Crit Care Med. 2012;40(1):11\u20137.","DOI":"10.1097\/CCM.0b013e31822f0604"},{"key":"202_CR27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jama.282.6.554","volume":"282","author":"DL Veenstra","year":"1999","unstructured":"Veenstra DL, Sain S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. J Am Med Assoc. 1999;282:554\u201360.","journal-title":"J Am Med Assoc"},{"issue":"8","key":"202_CR28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ajic.2010.11.008","volume":"39","author":"X Ye","year":"2011","unstructured":"Ye X, Rupnow M, Bastide P, Lafuma A, Ovington L, Jarvis WR. Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States. Am J Infect Control. 2011;39(8):647\u201354.","journal-title":"Am J Infect Control"},{"issue":"7","key":"202_CR29","doi-asserted-by":"crossref","first-page":"A564","DOI":"10.1016\/j.jval.2014.08.1869","volume":"17","author":"F Maunoury","year":"2014","unstructured":"Maunoury F, Motrunich A, Palka-Santini M. Cost-effectiveness modeling of antimicrobial dressings for preventing catheter-related bloodstream infection: Homogeneous versus non-homogeneous Markov approaches. Value Health. 2014;17(7):A564.","journal-title":"Value Health."},{"issue":"7","key":"202_CR30","doi-asserted-by":"crossref","first-page":"A356","DOI":"10.1016\/j.jval.2013.08.197","volume":"16","author":"F Maunoury","year":"2013","unstructured":"Maunoury F, Motrunich A, Ruckly S, Timsit JF. Non-homogeneous cost-effectiveness modeling of a new chgdressing for preventing catheter-related bloodstream infections for patients in intensive care units. Value Health. 2013;16(7):A356.","journal-title":"Value Health."},{"issue":"3","key":"202_CR31","first-page":"229","volume":"15","author":"M Palka-Santini","year":"2014","unstructured":"Palka-Santini M, Maunoury F, Motrunich A, Ruckly S, Timsit JF. Cost-effectiveness analysis of a new CHG-dressing for preventing catheter-related bloodstream infections. J Vasc Access. 2014;15(3):229\u201330.","journal-title":"J Vasc Access."},{"issue":"7","key":"202_CR32","doi-asserted-by":"crossref","first-page":"A560","DOI":"10.1016\/j.jval.2014.08.1849","volume":"17","author":"M Palka-Santini","year":"2014","unstructured":"Palka-Santini M, Motrunich A, Maunoury F. Cost-effectiveness analysis of an antimicrobial transparent dressing for protecting central vascular accesses in critically ill patients versus standard transparent dressings in France: a comparison of two modeling approaches: decision-tree versus non-homogeneous Markov model. Value in Health. 2014;17(7):A560.","journal-title":"Value in Health."},{"key":"202_CR33","unstructured":"Welsh Healthcare Associated Infection Programme. Central Venous Catheter (CVC) Infection and Ventilator Associated Pneumonia (VAP) in Critical Care\u2014Annual Report. 2014. http:\/\/www2.nphs.wales.nhs.uk:8080\/WHAIPDocs.nsf\/($All)\/28459C38515ACCAC80257D79005253C4\/$File\/Aneurin%20Bevan%20Critical%20Care%20CVC%20%26%20VAP%20Report%202013.pdf?OpenElement. Accessed 8 Jan 2015."},{"issue":"9","key":"202_CR34","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/archsurg.1996.01430210084018","volume":"131","author":"LB Pemberton","year":"1996","unstructured":"Pemberton LB, Ross V, Cuddy P, Kremer H, Fessler T, McGurk E. No difference in catheter sepsis between standard and antiseptic central venous catheters. A prospective randomized trial. Arch Surg. 1996;131(9):986\u20139.","journal-title":"Arch Surg."},{"key":"202_CR35","unstructured":"NHS. NHS Supply Chain Website. http:\/\/www.supplychain.nhs.uk\/ . Accessed 7 Jan 2015."},{"key":"202_CR36","unstructured":"Health Protection Scotland. Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units. Annual report of data from January\u2013December 2013. 2014. http:\/\/www.documents.hps.scot.nhs.uk\/hai\/sshaip\/publications\/icu-surveillance\/icu-annual-report-2014.pdf . Accessed 6 Jan 2015."},{"key":"202_CR37","doi-asserted-by":"crossref","unstructured":"National Institute for Health and Care Excellence. Medical Technologies Consultation Document: The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites. 2015. https:\/\/www.nice.org.uk\/guidance\/gid-mt238\/documents\/the-3m-tegaderm-chg-iv-securement-dressing-for-central-venous-and-arterial-catheter-insertion-sites-consultation-document2 . Accessed 14 May 2015.","DOI":"10.1007\/s40258-015-0202-5"},{"issue":"Suppl 1","key":"202_CR38","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0195-6701(13)60012-2","volume":"86","author":"HP Loveday","year":"2014","unstructured":"Loveday HP, Wilson JA, Pratt RJ, Golsorkhi M, Tingle A, Bak A, et al. epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2014;86(Suppl 1):S1\u201370.","journal-title":"J Hosp Infect."},{"issue":"6","key":"202_CR39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1086\/501776","volume":"21","author":"S Saint","year":"2000","unstructured":"Saint S, Veenstra DL, Lipsky BA. The clinical and economic consequences of nosocomial central venous catheter-related infection\u2014are antimicrobial catheters useful? Infect Control Hosp Epidemiol. 2000;21(6):375\u201380.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"202_CR40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/jac\/dkl234","volume":"58","author":"KM Ho","year":"2006","unstructured":"Ho KM, Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother. 2006;58(2):281\u20137.","journal-title":"J Antimicrob Chemother"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-015-0202-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40258-015-0202-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-015-0202-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T11:39:32Z","timestamp":1567251572000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40258-015-0202-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,12]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["202"],"URL":"https:\/\/doi.org\/10.1007\/s40258-015-0202-5","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,12]]}}}